Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
出版年份 2015 全文链接
标题
Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
作者
关键词
Ascites, Ovarian cancer, Tumor microenvironment, Cytokines, Inflammation, Drug resistance
出版物
BMC CANCER
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-06-30
DOI
10.1186/s12885-015-1511-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions
- (2015) Anita Chudecka-Glaz et al. OncoTargets and Therapy
- MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
- (2014) Isabelle Matte et al. BMC CANCER
- Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation
- (2014) Hong Qiong Yan et al. CANCER SCIENCE
- MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
- (2014) Mildred Felder et al. Molecular Cancer
- Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis
- (2013) Denis Lane et al. Journal of Ovarian Research
- Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment
- (2013) Jeremy Chien et al. Frontiers in Oncology
- The role of interleukin-6 in gynaecological malignancies
- (2012) Jermaine I.G. Coward et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
- (2012) Sharon Cohen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
- (2012) Nadzeya Goncharenko-Khaider et al. Molecular Cancer
- Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
- (2012) He Huang et al. PLoS One
- Integrated Analysis of Gene Expression Profiles Associated with Response of Platinum/Paclitaxel-Based Treatment in Epithelial Ovarian Cancer
- (2012) Yong Han et al. PLoS One
- Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
- (2012) Denis Lane et al. Journal of Ovarian Research
- Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
- (2011) Denis Lane et al. BMC CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells
- (2011) I Lakshmanan et al. ONCOGENE
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
- (2011) Rafael Molina et al. TUMOR BIOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines
- (2010) Li Zeng et al. CYTOKINE
- Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis
- (2010) Mian M. K. Shahzad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ovarian cancer ascites protects from TRAIL-induced cell death through αvβ5 integrin-mediated focal adhesion kinase and Akt activation
- (2010) D Lane et al. ONCOGENE
- The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer
- (2010) Denis Lane et al. Journal of Ovarian Research
- CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis
- (2009) Marianne Boivin et al. GYNECOLOGIC ONCOLOGY
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- Mining the plasma proteome for cancer biomarkers
- (2008) Samir M. Hanash et al. NATURE
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now